LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| MCF 10A | AT-7519 | 0.7769 |
| MCF 10A | Afatinib | 0.9528 |
| MCF 10A | A443654 | 0.7938 |
| MCF 10A | GW843682X | 0.6799 |
| MCF 10A | NVP-TAE684 | 0.4189 |
| MCF 10A | Luminespib | 1.0584 |
| MCF 10A | NVP-AEW541 | 0.1825 |
| MCF 10A | NU7441 | 0.0910 |
| MCF 10A | Nilotinib | 0.0600 |
| MCF 10A | Neratinib | 0.7660 |
| MCF 10A | MK2206 | 0.1794 |
| MCF 10A | Mitoxantrone | 1.0401 |
| MCF 10A | Linsitinib | 0.1886 |
| MCF 10A | Linifanib | 0.0081 |
| MCF 10A | LDN-193189 | 0.2211 |
| MCF 10A | Lapatinib | 0.1647 |
| MCF 10A | KIN001-043 | 0.1013 |
| MCF 10A | JW-7-24-1 | 0.1490 |
| MCF 10A | JNK-9L | 0.6014 |
| MCF 10A | Nintedanib | 0.0234 |
| MCF 10A | Imatinib | -0.0040 |
| MCF 10A | HG-6-64-01 | 0.2184 |
| MCF 10A | HG-5-88-01 | 0.2644 |
| MCF 10A | HG-5-113-01 | 0.3487 |
| MCF 10A | Seliciclib | 0.0913 |